non-clear cell kidney cancer trial updates: calypso and keynote-427
Published 5 years ago • 120 plays • Length 4:10Download video MP4
Download video MP3
Similar videos
-
1:29
advances in non-clear cell kidney cancer
-
1:02
non-clear cell sarcamatoid kidney cancer treatment updates
-
0:59
combining lenvatinib & pembrolizumab for non-clear cell rcc: keynote-b61 study rationale
-
1:20
promising results of cabozantinib plus nivolumab in non-clear cell rcc
-
4:20
trial updates in mrcc from asco: keynote-427, resort, e2810 & immotion151
-
4:21
kidney tumor 3 years later: update
-
10:24
the typical prognosis of aggressive renal cell cancer
-
36:53
take control of kidney cancer: what you need to know
-
1:28
keynote-b61: first-line lenvatinib pembrolizumab in non-clear cell rcc
-
1:17
treating non-clear cell renal cell carcinoma patients
-
13:28
keynote-b61 study results and a focus on non-clear cell kidney cancer
-
4:57
review of the data of frontline treatment for non-clear cell kidney cancer
-
1:15
renal cell carcinoma - an osmosis preview
-
1:46
clinical trials in kidney cancer to look out for
-
8:31
current concepts in the treatment of non-clear cell kidney cancer
-
2:16
updated results from keynote-426 for metastatic kidney cancer
-
4:02
atezolizumab plus bevacizumab in non-clear cell, sarcomatoid kidney cancer
-
2:16
savolitinib plus durvalumab show promise in papillary renal cancer: calypso results
-
2:25
dr. tykodi on the keynote-427 trial with pembrolizumab in rcc
-
0:59
updates in kidney cancer at esmo 2022
-
3:01
non-clear cell kidney cancer: dr. elizabeth henske discusses variant histologies & therapies
-
11:52
renal cell carcinoma (kidney cancer) - a tutorial by oster oncology